Molecules, Volume 23, Issue 1 (January 2018) – 219 articles
Cover Story (view full-size image): These are small molecules with a 10-carbon skeleton called monoterpenes, which show great structural diversity within the iridoids group. The aglycone and glycoside forms of these compounds appear to target several pathological markers of Alzheimer’s disease both in vitro and in animal models. At a molecular level, beta amyloids (Aβ) formation, precipitation and neurotoxicity, mechanisms of tau phosphorylation, reactive oxygen species-Aβ crosstalk, and various oxidative and inflammatory cascades are targeted. What then would the prospects of these compounds be as drugs? View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
- You may sign up for e-mail alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.